EchoSolv AS vs Viz HCM
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your primary need is to accurately and efficiently identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This tool is ideal for cardiology departments seeking to prioritize studies for closer review and streamline their diagnostic workflow without requiring extensive EMR integration.
View EchoSolv AS →Choose Viz HCM if…
Choose Viz HCM if your priority is real-time detection of suspected Hypertrophic Cardiomyopathy directly from ECG analysis and immediate, coordinated care team activation. This solution is best suited for health systems aiming to significantly reduce HCM diagnosis time and automate patient direction to appropriate specialists through seamless integration with EHR and PACS.
View Viz HCM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | Viz HCM |
|---|---|---|
| Deployment | Cloud-based | Unknown |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMWhile both tools integrate into existing workflows, Viz HCM offers a more comprehensive and proactive user experience. It provides real-time detection, mobile-based alerts, and automated care coordination, which streamlines workflows for multidisciplinary teams. EchoSolv AS focuses on ultra-fast analysis and PACS integration without requiring EMR integration, which is simpler but less integrated into the broader care pathway.
Clinical Value
Viz HCMBoth tools are FDA-cleared and offer significant clinical value for their respective conditions. Viz HCM explicitly highlights 'extensive real-world evidence and publications' and focuses on 'significantly reducing diagnosis time' and 'time to treatment' for HCM. EchoSolv AS also demonstrates high accuracy and efficiency in identifying severe AS, with studies showing it can outperform traditional interpretation and reduce delays in diagnosis. However, Viz HCM's emphasis on reducing time to *treatment* and its broad publication record give it a slight edge in demonstrating tangible impact on patient outcomes.
Pricing & Value
Viz HCMViz HCM provides transparent information about its subscription-based pricing model and, critically, mentions CMS reimbursement available for specific CPT codes (0764T and 0765T). This clear path to reimbursement significantly enhances its financial value proposition for healthcare systems. EchoSolv AS, while also subscription-based and having a mapped pathway toward a dedicated Category III CPT code expected in mid-2025, does not provide specific pricing details or current reimbursement codes in the provided information, making a direct comparison of value difficult.
Enterprise Readiness
Viz HCMBoth tools are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs, indicating strong foundational enterprise readiness. However, Viz HCM explicitly states 'integrated into hospital IT systems (EHR, PACS)' and 'seamless integration with existing clinical workflows, EHR, and PACS systems,' suggesting a deeper and broader integration capability within complex hospital IT ecosystems. While EchoSolv AS emphasizes 'no EMR integration required,' Viz HCM's comprehensive EHR integration points to a more holistic enterprise solution.
Innovation
Viz HCMWhile EchoSolv AS demonstrates innovation with its 'measurement-based AI' that analyzes numerical data and 'ultra-fast risk detection' (under 3 seconds), Viz HCM's innovation extends beyond just detection. Viz HCM integrates AI into 'real-time disease detection,' 'mobile-based alerts,' and 'automated direction of patients to appropriate care specialists,' representing a broader innovation in care coordination and workflow automation driven by AI. This proactive approach to transforming the entire care pathway gives Viz HCM an edge in innovation.
Support & Docs
Viz HCMViz HCM explicitly details its customer support, including a dedicated customer success team, clinical and workflow specialists, and 24/7 urgent support via phone and in-app contact. EchoSolv AS mentions 'Feedback & Support' on its website but does not provide specific details on support tiers, documentation, or response times. Therefore, Viz HCM demonstrates a more robust and transparent support structure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | Viz HCM |
|---|---|---|
| Target Condition | Severe Aortic Stenosis (sAS) | Hypertrophic Cardiomyopathy (HCM) |
| Analysis Method | AI-powered clinical decision support for severe aortic stenosis probability, measurement-based AI (analyzes numerical measurements, not images) | AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, real-time disease detection from electrocardiograms |
| Data Input | Numerical measurements (AI does not use LVOT measurements) | Real-time ECG analysis |
| System Integration | Designed to fit existing workflows (no EMR integration required, integrates with PACS) | Seamless integration with existing clinical workflows, EHR, and PACS systems |
| Alerts/Notifications | Second reader support to help prioritize studies for closer review | Mobile-based alerts and notifications to multidisciplinary care teams, automated direction of patients to appropriate care specialists |
| Primary Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Emergency Medicine, Hospital Medicine |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and Viz HCM.